Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional) | RFA DK 24 002

Opportunity Information: Apply for RFA DK 24 002

This National Institutes of Health (NIH) funding opportunity, RFA-DK-24-002, supports R01 research projects focused on improving diabetes management for older adults (age 65 and up) living with type 1 diabetes (T1D) by developing and testing diabetes control technologies that better fit the realities of aging. The central goal is to encourage technologies that are responsive to age-related changes that can make standard diabetes tools harder to use or potentially riskier, including higher vulnerability to hypoglycemia, hypoglycemia unawareness, cognitive impairment, and the presence of multiple chronic conditions. The expectation is that technologies designed or modified with older adults in mind will be easier to use and stick with in day-to-day life, leading to safer glycemic outcomes and better quality of life for both patients and caregivers.

The announcement is especially interested in two broad types of projects. The first category is the development and testing of new technologies created specifically to address barriers older adults face when using diabetes devices or digital tools. The second category is the adaptation and testing of existing technologies, meaning investigators can take tools already used in other T1D populations and redesign or tailor them to account for aging-related needs. Across both categories, the underlying emphasis is on practical usability and real-world adoption, not just technical performance. Projects should be positioned to show how an aging-adaptive approach could reduce hypoglycemia risk while also improving overall glycemic control, simplifying diabetes self-management, and supporting independence and well-being.

This is an R01 grant mechanism with clinical trials listed as optional, so applicants may propose studies that include a clinical trial component if it fits the technology and research questions, but a clinical trial is not required. The funding instrument is a discretionary grant in the health and nutrition area, associated with CFDA number 93.847. The listed award ceiling is $500,000, indicating the maximum amount allowed under the opportunity (as provided in the source summary).

A wide range of organizations are eligible to apply. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (outside of higher education institutions); for-profit organizations other than small businesses; and small businesses. The announcement also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; U.S. territories or possessions; regional organizations; and even non-U.S. entities (foreign organizations), indicating an intentionally broad applicant pool.

Key administrative details from the source information include an original closing date of July 17, 2024, and a creation date of April 1, 2024. Overall, the opportunity is aimed at pushing diabetes technology research toward designs that reflect the lived experience of older adults with T1D, with the practical intent of improving safety (especially around hypoglycemia), strengthening day-to-day management, and increasing quality of life for older individuals and the people who help care for them.

• The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
• This funding opportunity was created on 2024-04-01.
• Applicants must submit their applications by 2024-07-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DK 24 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: